TY - JOUR
T1 - Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period
AU - Savino, Gustavo
AU - Piccinni, Fabrizio
AU - Pagliara, Monica Maria
AU - Sammarco, Maria Grazia
AU - Caputo, Carmela Grazia
AU - Moro, Alessandro
AU - Barbera, Giorgio
AU - Tagliaferri, Luca
AU - Fionda, Bruno
AU - Schinzari, Giovanni
AU - Rossi, Ernesto
AU - Zagaria, Luca
AU - Peris, Ketty
AU - Di Stefani, Alessandro
AU - Musarra, Teresa
AU - Ausili Cefaro, Luca
AU - Martucci, Matia
AU - Blasi, Maria Antonietta
PY - 2022
Y1 - 2022
N2 - Purpose: The complexity of multimodal approaches in cancer management has lately led to the establishment of multidisciplinary tumor boards (MDTBs) to define targeted, patient-centered treatment strategies. However, few data are available regarding the application of this approach in Ocular Oncology. Hereby, the Authors analyze the implementation and outcomes of a trained MDTB in a tertiary ocular oncology referral center. Methods: A retrospective descriptive analysis of MDTB meetings discussing patients with ocular and periocular cancers, over a 12-months period, was carried out. Data were grouped by main site involved, topics discussed and final clinical decisions therefore taken. Meetings were held by a constant 'Core team' or - when required - by a broader 'Extended team'. Results: During the observational period 86 cases were discussed. In 27 patients ocular surface tissues were involved (31%), in 25 patients orbital tissues (29%), in 22 patients eyelids (26%), and in 12 patients intraocular tissues (14%). In 13 cases (15%) naïve or referred new patients, in 34 cases (40%) imaging or histopathologic reports and in 39 cases (45%) treatment plans were discussed. Regarding final decisions, a treatment plan was scheduled in 47 cases (55%) and a diagnostic ascertainment was required in 27 patients (31%); locally advanced and/or systemic diseases were referred or teamed up with other specialists in 12 cases (14%). Conclusions: Ocular Oncology multidisciplinary team, by sharing expertise of different specialists, ensures a comprehensive evaluation of patients improving the accuracy of diagnosis and staging upon which planning a proper treatment. Further studies are needed to assess if this approach may also improve the outcomes and prognosis of patients.
AB - Purpose: The complexity of multimodal approaches in cancer management has lately led to the establishment of multidisciplinary tumor boards (MDTBs) to define targeted, patient-centered treatment strategies. However, few data are available regarding the application of this approach in Ocular Oncology. Hereby, the Authors analyze the implementation and outcomes of a trained MDTB in a tertiary ocular oncology referral center. Methods: A retrospective descriptive analysis of MDTB meetings discussing patients with ocular and periocular cancers, over a 12-months period, was carried out. Data were grouped by main site involved, topics discussed and final clinical decisions therefore taken. Meetings were held by a constant 'Core team' or - when required - by a broader 'Extended team'. Results: During the observational period 86 cases were discussed. In 27 patients ocular surface tissues were involved (31%), in 25 patients orbital tissues (29%), in 22 patients eyelids (26%), and in 12 patients intraocular tissues (14%). In 13 cases (15%) naïve or referred new patients, in 34 cases (40%) imaging or histopathologic reports and in 39 cases (45%) treatment plans were discussed. Regarding final decisions, a treatment plan was scheduled in 47 cases (55%) and a diagnostic ascertainment was required in 27 patients (31%); locally advanced and/or systemic diseases were referred or teamed up with other specialists in 12 cases (14%). Conclusions: Ocular Oncology multidisciplinary team, by sharing expertise of different specialists, ensures a comprehensive evaluation of patients improving the accuracy of diagnosis and staging upon which planning a proper treatment. Further studies are needed to assess if this approach may also improve the outcomes and prognosis of patients.
KW - Multidisciplinary team
KW - Ocular MDTB
KW - Ocular oncology
KW - Ocular oncology multidisciplinary tumor board
KW - Oncology
KW - Ophthalmology
KW - Multidisciplinary team
KW - Ocular MDTB
KW - Ocular oncology
KW - Ocular oncology multidisciplinary tumor board
KW - Oncology
KW - Ophthalmology
UR - https://publicatt.unicatt.it/handle/10807/222625
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85144296156&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85144296156&origin=inward
U2 - 10.1186/s12886-022-02694-3
DO - 10.1186/s12886-022-02694-3
M3 - Article
SN - 1471-2415
VL - 22
SP - 497
EP - 506
JO - BMC Ophthalmology
JF - BMC Ophthalmology
IS - 1
ER -